Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Functional characterization of muscarinic autoreceptors in rat and human neocortex.

Stoll C, Eltze M, Lambrecht G, Zentner J, Feuerstein TJ, Jackisch R.

J Neurochem. 2009 Aug;110(3):837-47. doi: 10.1111/j.1471-4159.2009.06193.x. Epub 2009 May 29.

2.

Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.

Klein T, Eltze M, Grebe T, Hatzelmann A, Kömhoff M.

Cardiovasc Res. 2007 Jul 15;75(2):390-7. Epub 2007 Feb 28.

PMID:
17383621
3.

Montelukast exerts no acute direct effect on NO synthases.

Hamacher J, Eichert K, Braun C, Grebe T, Strub A, Lucas R, Eltze M, Wendel A.

Pulm Pharmacol Ther. 2007;20(5):525-33. Epub 2006 May 19.

PMID:
16815057
4.

In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase.

Lehner MD, Marx D, Boer R, Strub A, Hesslinger C, Eltze M, Ulrich WR, Schwoebel F, Schermuly RT, Barsig J.

J Pharmacol Exp Ther. 2006 Apr;317(1):181-7. Epub 2005 Dec 20.

PMID:
16368897
5.

The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.

Strub A, Ulrich WR, Hesslinger C, Eltze M, Fuchss T, Strassner J, Strand S, Lehner MD, Boer R.

Mol Pharmacol. 2006 Jan;69(1):328-37. Epub 2005 Oct 13.

PMID:
16223957
6.

Evidence that alpha(1B)-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery.

Jähnichen S, Eltze M, Pertz HH.

Eur J Pharmacol. 2004 Mar 19;488(1-3):157-67.

PMID:
15044047
7.

Affinity profile at alpha(1)- and alpha(2)-adrenoceptor subtypes and in vitro cardiovascular actions of (+)-boldine.

Eltze M, Grebe T, Michel MC, Czyborra P, Ullrich B.

Eur J Pharmacol. 2002 May 17;443(1-3):151-68.

PMID:
12044805
8.

In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.

Eltze M, Boer R, Michel MC, Hein P, Testa R, Ulrich WR, Kolassa N, Sanders KH.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):649-62.

PMID:
11414660
9.
10.

In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.

Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R.

J Pharmacol Exp Ther. 2001 Apr;297(1):280-90.

PMID:
11259555
11.

Buspirone functionally discriminates tissues endowed with alpha1-adrenoceptor subtypes A, B, D and L.

Eltze M, König H, Ullrich B, Grebe T.

Eur J Pharmacol. 1999 Jul 28;378(1):69-83.

PMID:
10478567
12.

Multiple mechanisms of action: the pharmacological profile of budipine.

Eltze M.

J Neural Transm Suppl. 1999;56:83-105. Review.

PMID:
10370904
13.
14.

Contraction of guinea-pig gallbladder: muscarinic M3 or M4 receptors?

Eltze M, König H, Ullrich B, Grebe T.

Eur J Pharmacol. 1997 Jul 30;332(1):77-87.

PMID:
9298928
15.
16.

Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney.

Eltze M, Ullrich B.

Eur J Pharmacol. 1996 Jun 13;306(1-3):139-52.

PMID:
8813626
18.
19.
21.

Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney.

Eltze M, Ullrich B, Mutschler E, Moser U, Bungardt E, Friebe T, Gubitz C, Tacke R, Lambrecht G.

Eur J Pharmacol. 1993 Jul 20;238(2-3):343-55.

PMID:
8405103
23.
24.
26.
27.
28.

Telenzepine and its enantiomers, M1-selective antimuscarinics, in guinea pig lung function tests.

Kilian U, Beume R, Eltze M, Häfner D, Hanauer G, Schudt C.

Agents Actions Suppl. 1991;34:131-47. Review. No abstract available.

PMID:
1793060
29.

Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.

Schudt C, Winder S, Eltze M, Kilian U, Beume R.

Agents Actions Suppl. 1991;34:379-402. Review.

PMID:
1665311
30.

Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.

Eltze M.

Eur J Pharmacol. 1990 May 3;180(1):161-8.

PMID:
2365000
31.

Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.

Kromer W, Baron E, Beinborn M, Boer R, Eltze M.

Naunyn Schmiedebergs Arch Pharmacol. 1990 Mar;341(3):165-70.

PMID:
1692974
32.

Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.

Eltze M, Boer R, Sanders KH, Boss H, Ulrich WR, Flockerzi D.

Chirality. 1990;2(4):233-40.

PMID:
1964575
33.

Cyproheptadine displays high affinity for muscarinic receptors but does not discriminate between receptor subtypes.

Eltze M, Lambrecht G, Mutschler E.

Eur J Pharmacol. 1989 Dec 7;173(2-3):219-22.

PMID:
2625138
34.

Affinity profiles of BTM-1086 and BTM-1041 at muscarinic receptor subtypes and at H1- and alpha 1-receptors.

Eltze M, Boer R, Mutschler E, Lambrecht G.

Eur J Pharmacol. 1989 Nov 7;170(3):225-34.

PMID:
2575995
35.

Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells.

Kromer W, Baron E, Beinborn M, Eltze M, Simon WA.

Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):68-75.

PMID:
2477717
36.
37.

The affinity, selectivity and biological activity of telenzepine enantiomers.

Schudt C, Boer R, Eltze M, Riedel R, Grundler G, Birdsall NJ.

Eur J Pharmacol. 1989 Jun 8;165(1):87-96.

PMID:
2475354
38.
39.

Is phosphodiesterase inhibition a relevant bronchospasmolytic principle?

Kilian U, Beume R, Eltze M, Schudt C.

Agents Actions Suppl. 1989;28:331-48. Review. No abstract available.

PMID:
2683636
40.

Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes.

Eltze M, Figala V.

Eur J Pharmacol. 1988 Dec 6;158(1-2):11-9.

PMID:
3220113
41.
42.

Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.

Riedel R, Bohnenkamp W, Eltze M, Heintze K, Prinz W, Kromer W.

Digestion. 1988;40(1):25-32.

PMID:
3234616
44.

Specificity of the substituted benzimidazole B 823-08: a prodrug for gastric proton pump inhibition.

Bohnenkamp W, Eltze M, Heintze K, Kromer W, Riedel R, Schudt C.

Pharmacology. 1987;34(5):269-78.

PMID:
2956612
45.

Interaction with histamine H1-receptors and bronchospasmolytic effects of urapidil.

Kilian U, Eltze M, Kolassa N.

Respiration. 1987;51(1):16-25.

PMID:
2882573
46.

The sulphoxide moiety of substituted benzimidazoles is essential for inhibition of parietal cell K+/H+-ATPase.

Beil W, Eltze M, Heintze K, Klemm K, Riedel R, Schudt C, Sewing KF, Simon A.

Br J Pharmacol. 1986 Jun;88(2):389-95.

47.

Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.

Eltze M, Gönne S, Riedel R, Schlotke B, Schudt C, Simon WA.

Eur J Pharmacol. 1985 Jun 7;112(2):211-24.

PMID:
4029260
48.

Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo.

Zech K, Eltze M, Kilian U, Sanders KH, Kolassa N.

Arch Int Pharmacodyn Ther. 1984 Dec;272(2):180-96.

PMID:
6098228
49.

[Pharmacology of ethylenediamine and its interaction with theophylline].

Baccouche M, Dittmann EC, Eltze M, Kilian U.

Prax Klin Pneumol. 1983 Aug;37(8):322-5. German. No abstract available.

PMID:
6622384
50.

Supplemental Content

Support Center